Discover the new migraine medications, such as monoclonal antibodies and gepants, that are changing migraine treatment for ...

Reported cumulative MMR rate of 47% (25 of 53) by 24 weeks with 32% (13 of 41) of patients achieving MMR by 24 weeks, which continues to compare favorably to precedent ...